GeneAssist Therapeutics has snapped “several tens of millions” in US dollars in its Series A round; Singular Medical has snapped “several hundreds of millions” yuan in a Series B+ round; and Witmem Technology has notched 200 million yuan in a Series B2 round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
